Experience

Davis Polk is advising Bio-Reference Laboratories, Inc. in connection with its approximately $1.47 billion acquisition by OPKO Health, Inc. Under the terms of the agreement, holders of Bio…

Davis Polk is advising Warner Chilcott plc in connection with its approximately $8.5 billion acquisition by Actavis, Inc. in a stock-for-stock transaction. The transaction is expected to…

On August 5, 2011, the Office of Inspector General for the Department of Health and Human Services dropped a potential action against Davis Polk client Howard Solomon, the President,…

Davis Polk represented VNUS Medical in patent infringement litigation since 2005 in the Northern District of California. VNUS, the pioneer in endovenous treatment for varicose veins, sued…

On January 20, 2009, the Delaware Court of Chancery heard oral argument and denied a Ventana Medical Systems, Inc. shareholder’s mootness petition for attorneys’ fees against Davis Polk…